Key result
Coronary collateral development limits ischemic myocardial necrosis and offers multiple avenues for in vivo assessment.
Why the study?
The variability in presentation, symptoms, and outcomes in coronary atherosclerosis patients may be explained by the presence and recruitment of collateral vessels, but their assessment and significance require further understanding.
This review summarizes the physiology, development, and in vivo assessment of coronary collateral vessels in patients with coronary atherosclerosis.
Collateral development may limit necrosis in ischemia; leaves open standardized in vivo assessment and angiogenic therapies.
The existence and recruitment of collateral vessels within the coronary circulation may account for the tremendous variability in presentation, symptoms and outcome in patients with coronary atherosclerosis. Multiple episodes of ischemia have been found to produce the stimuli necessary for the growth of new vessels which result in collateral blood flow. Furthermore, there is also a subset of patients with readily recruitable collateral vessels that function to limit myocardial necrosis during an acute ischemic event. Promising early studies have utilized angiogenic growth factors as a means to stimulate collateral growth, bringing a renewal interest in their assessment and significance. We review, in brief, the significance and understanding of the development of coronary collaterals as well as the available means to assess them.
No takes yet. Share an insight, caveat, or question.
Lim et al. (2004) conducted a review in Coronary atherosclerosis. This review highlights the significance of coronary collateral development in limiting myocardial necrosis during ischemia and discusses available methods for their in vivo assessment.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: